Moreover, the first demonstrated a positive correlation between CTSS levels and the proportion of anti-apoptotic subclasses HDL3a and HDL3b, which will enhance the understanding of disease mechanisms in NHL, potentially contributing to the development of new therapeutic strategies for this cancer. The gene discussed is CTSS; the disease is non-Hodgkin lymphoma.